A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma

Human Gene Therapy

Volumn 8, Issue 11, 1997, Pages 1403-1414

  Stewart, A K ^a,c   Lassam, N J ^a,d   Graham, F L ^e   Gauldie, J ^e   Addison, C L ^e   Bailey, D J ^b   Dessureault, S ^b   Dube I D ^b   Gallenger, S ^b,d   Krajden, M ^a,c   Rotstein, L E ^b   Quirt, I C ^a   Moen, R ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f Baxter Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ADENOVIRUS; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; GENE TRANSFER; HUMAN; MELANOMA; METASTASIS; PHASE 1 CLINICAL TRIAL;

ADENOVIRIDAE;

EID: 16944367069     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.11-1403     Document Type: Article

References (61)

1. Recombinant DNA advisory committee data management report Human Gene Therapy 5 1295, (1994)
2. TJ Tsomides and HN Eisen, Proc. Natl. Acad. Sci. USA, 91, 3487 (1994)
3. PG Coulie et al, J. Immunother., 14, 104 (1993) Y. Kawakami et al, J. Immunother., 14, 88 (1993)
4. PG Coulie et al, J. Immunother., 14, 104 (1993) Y. Kawakami et al, J. Immunother., 14, 88 (1993)
5. AL Cox et al, Science, 264, 716 (1994); Y Kawakami et al, Proc Natl Acad Sci USA, 91, 3535 (1994)
6. AL Cox et al, Science, 264, 716 (1994); Y Kawakami et al, Proc Natl Acad Sci USA, 91, 3535 (1994)
7. O Mandelbolm et al, Nature, 369, 67, (1994)
8. SL Topalian, A Kasix, SA Rosenberg, J Immunol, 144, 4487 (1990)
9. S. Topalian, D Solomon, SA Rosenberg, J Immunol, 142, 3714 1989)
10. CD Gimmi et al, Proc Natl Acad Sci USA, 88, 6575 (1991); PS Linsley et al, J. Exp. Med., 173, 721 (1991)
11. CD Gimmi et al, Proc Natl Acad Sci USA, 88, 6575 (1991); PS Linsley et al, J. Exp. Med., 173, 721 (1991)
12. S.E. Townsend and J.P. Allison, Science, 259, 368 (1993)
13. D. Pardoll, TIBS, 14, 202 (1993)
14. E.R. Fearon et al, Cell, 60. 397 (1990)
15. M.T. Lotze et al, Cancer Res., 41, 4420 (1981); E.A. Grimm, A, Mazumder, H.Z. Zhang, S.A. Rosenberg, J. Exp. Med., 155, 1823 (1982)
16. M.T. Lotze et al, Cancer Res., 41, 4420 (1981); E.A. Grimm, A, Mazumder, H.Z. Zhang, S.A. Rosenberg, J. Exp. Med., 155, 1823 (1982)
17. R.B. Cameron, P.J. Spiess, S.A. Rosenberg, J. Exp. Med., 171, 249 (1990); C.G. Lindgren, J.A. Thompson, C.M. Higuchi, A. Fefer, J. Immunotherapy, 14, 322 (1993)
18. R.B. Cameron, P.J. Spiess, S.A. Rosenberg, J. Exp. Med., 171, 249 (1990); C.G. Lindgren, J.A. Thompson, C.M. Higuchi, A. Fefer, J. Immunotherapy, 14, 322 (1993)
19. T.J. Eberlein and D.D. Schoof, Comp. Therapy, 17, 49 (1991)
20. J.P. Siegel and R.K. Puri, J. Clin. Oncol., 9, 694 (1991)
21. R.S. Yeung, C. Vollmer, D.D. Taylor, J. Palazzo, J.L. Weese, J. Surgical Res., 53, 203 (1992); A. Tohmatsu et al, Immunol. Letters, 35, 51 (1993)
22. R.S. Yeung, C. Vollmer, D.D. Taylor, J. Palazzo, J.L. Weese, J. Surgical Res., 53, 203 (1992); A. Tohmatsu et al, Immunol. Letters, 35, 51 (1993)
23. E.R. Fearon, D.M. Pardoll, T. Itaya et al, Cell, 60:937, (1990); S.E. Karp et al, J. Immunol., 150, 896 (1993)
24. E.R. Fearon, D.M. Pardoll, T. Itaya et al, Cell, 60:937, (1990); S.E. Karp et al, J. Immunol., 150, 896 (1993)
25. M.A. Rosenfeld et al, Science, 252, 431 (1991); M.A. Rosenfeld et al, Cell, 68, 143 (1992); H. Haddada, T, Ragot, L. Cordien, M.T. Duffour, M. Perricaudet, Hum. Gene Ther., 4, 703 (1993); T. Ragot et al, Nature, 361, 647 (1993); K.M. Wills et al, Hum. Gene Ther., 5, 1079 (1994)
26. M.A. Rosenfeld et al, Science, 252, 431 (1991); M.A. Rosenfeld et al, Cell, 68, 143 (1992); H. Haddada, T, Ragot, L. Cordien, M.T. Duffour, M. Perricaudet, Hum. Gene Ther., 4, 703 (1993); T. Ragot et al, Nature, 361, 647 (1993); K.M. Wills et al, Hum. Gene Ther., 5, 1079 (1994)
27. M.A. Rosenfeld et al, Science, 252, 431 (1991); M.A. Rosenfeld et al, Cell, 68, 143 (1992); H. Haddada, T, Ragot, L. Cordien, M.T. Duffour, M. Perricaudet, Hum. Gene Ther., 4, 703 (1993); T. Ragot et al, Nature, 361, 647 (1993); K.M. Wills et al, Hum. Gene Ther., 5, 1079 (1994)
28. M.A. Rosenfeld et al, Science, 252, 431 (1991); M.A. Rosenfeld et al, Cell, 68, 143 (1992); H. Haddada, T, Ragot, L. Cordien, M.T. Duffour, M. Perricaudet, Hum. Gene Ther., 4, 703 (1993); T. Ragot et al, Nature, 361, 647 (1993); K.M. Wills et al, Hum. Gene Ther., 5, 1079 (1994)
29. M.A. Rosenfeld et al, Science, 252, 431 (1991); M.A. Rosenfeld et al, Cell, 68, 143 (1992); H. Haddada, T, Ragot, L. Cordien, M.T. Duffour, M. Perricaudet, Hum. Gene Ther., 4, 703 (1993); T. Ragot et al, Nature, 361, 647 (1993); K.M. Wills et al, Hum. Gene Ther., 5, 1079 (1994)
30. J.R. Nevins, Microbiology Rev., 51, 419 (1987).
31. A.J. Bett, W. Haddara, L. Prevec, F.L. Graham, Proc. Natl. Acad. Sci. USA., 91, 8802 (1994).
32. M. Ruben, S. Bacchetti, F.L. Graham, J. Virol., 41, 674 (1982).
33. Y. Yang et al, Proc. Natl. Acad. Sci. USA, 91, 4407 (1994).
34. M.A. Bean et al, Cancer Res., 35, 2902 (1975)
35. R.D. Cardiff and W.J. Muller, in Cancer Surveys, 16 (CSH Laboratories Press, 1993) 97-113.
36. C.T. Guy, R.D. Cardiff, W.J. Muller, Mol. Cell. Biol., 12, 954 (1992).
37. Stratford-Perricaudet L, Perricaudet M. Human Gene Transfer, 1991, vol 219: 51-61
38. Brody SL, Crystal RG. Annals New York Academy of Sciences, 1994, vol 716:90-99
39. Yei S, Mittereder N, Wert S et al., (1994) Hum Gene Therapy 5, 731-744
40. Simon R, Engelhardt JF, Yang Y, et al., (1993) Hum Gene Therapy 4, 771-780
41. Prince GA, Porter DD, Jenson AB et al. J. Virol, 1993, 67, 101-111
42. Knight V (1983) In Harrison's, Principles of Internal Medicine, (eds Petersdorf, Adams, Braunwald, Isselbacher, Martin, Wilson)pub. McGraw Hill, pp1102-1104
43. Bell JA, Ward TG, Huebner RJ, Rowe WP, Suskind G, Paffenbarger RS. 1956 AM J Public Health 46: 1130-1146
44. Top FH, Jr BA Dudding, PK Russell, EL Buescher. 1971. Am J Epidemiol 94: 142-146
45. Smith RR, Huebner RJ, Rowe WP, Schatten WE, Thomas LB. 1956 Cancer 9: 1211-1218
46. Wilson JM, Engelhardt JF, Grossman M, Simon RH, Yang Y. Human Gene Therapy 5:501-519 (1994)
47. Wilmott RW, Whitsett JA, Trapnell B, et al. Human Gene Therapy 5:1019-1057 (August 1994)
48. Boucher RC, Knowles MR, Johnson LG et al. Human Gene Therapy 5:615-639 (1994)
49. Pavirani A, Bellon G J Cell Biochem, (1995) Suppl. 21A, 370
50. Mulligan RC. Science, Vol 260, 14 May 1993
51. Graham FL, Smiley J, Russell WC, Nairin R. 1977. J Gen Virol 36: 59-72
52. Bett AJ, Haddara W, Prevec L, Graham FL. Proc Natl Acad Sci USA (1994), Vol 91, 8802-8806
53. Yang Y, Nunes FA, Berencsi K, et al. Proc Natl Acad Sci, USA, Vol 91, pp. 4407-4411, May 1994.
54. Rich DP, Couture LA, Cardoza L, et al. (1993) Human Gene Therapy 4, 461-476
55. Engelhardt JF, Yang Y, Stratford-Perricaudet LD et al (1993) Nature Genetics, 4, 27-34
56. Mitani K, Graham F, Caskey CT (1994), Human Gene Therapy 5, 941-948
57. Bennet J, Wilson J, Sun D et al. (1994) Invest Ophthalmol. Visual Sci. (in press).
58. Davidson BL, Allen ED, Kozarsky KF et al. (1992) Nature Genet. 3, 219-223
59. Lochmuller H, Jani A, Huard J et al. (1994) Human Gene Therapy, 5, 1485-1491
60. Clinical Protocols (1995) Cancer Gene Therapy, 2, 67-94.
61. Crystal RG et al. Human Gene Therapy (1995) 6, 667-703